{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-31823494-dulaglutide:v1","objectPathId":"pubmed-pmid-31823494-dulaglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-31823494-dulaglutide/","json":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-31823494-dulaglutide-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-31823494-dulaglutide-v1.md"},"story":{"slug":"pubmed-pmid-31823494-dulaglutide","version":1,"domain":"Literature metadata","dateInSource":"2020-05-11","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["dulaglutide"],"peptides":[{"slug":"dulaglutide","url":"https://peptidescanner.com/peptides/dulaglutide/"}]},"claims":[{"id":"headline","text":"Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report.","sourceIds":["pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80"]},{"id":"summary","text":"PubMed lists PMID 31823494 in Geriatrics & gerontology international as Case Reports, Letter, with publication-date metadata of 2019-12 (month precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80"]},{"id":"paragraph-1","text":"PubMed lists PMID 31823494 in Geriatrics & gerontology international as Case Reports, Letter, with publication-date metadata of 2019-12 (month precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80"]}],"sources":[{"id":"pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80","name":"PubMed","sourceClass":"A","title":"Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report. · retained source version 1:2020-05-11:current:62a9d2797c800b8c730729cad2690cdc8bde686d630597158feb56a17cd82cac","url":"https://pubmed.ncbi.nlm.nih.gov/31823494/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"02c93f855c0f61b1e3c4731d84a031e88fdd166228d9078b5992313f1728a091","tierARecordSha256":"76a203fe748548a885dd9aac1fe83b43b8c13731935464eb614fc023055340c6"},"integrity":{"algorithm":"sha256","contentSha256":"59d21b64bf0ff1fed23dd34dd50940251ae9ad39f918c940bc2b46dc5dbad073"}}